The METEX study: Methotrexate versus expectant management in women with ectopic pregnancy: A randomised controlled trial

BACKGROUND: Patients with ectopic pregnancy (EP) and low serum hCG concentrations and women with a pregnancy of unknown location (PUL) and plateauing serum hCG levels are commonly treated with systemic methotrexate (MTX). However, there is no evidence that treatment in these particular subgroups of...

Descripción completa

Detalles Bibliográficos
Autores principales: van Mello, Norah M, Mol, Femke, Adriaanse, Albert H, Boss, Erik A, Dijkman, Antonius B, Doornbos, Johannes PR, Emanuel, Mark Hans, Friederich, Jaap, Leeuw-Harmsen, Loes van der, Lips, Jos P, van Santbrink, Evert JP, Verhoeve, Harold R, Visser, Harry, Ankum, Willem M, Veen, Fulco van der, Mol, Ben W, Hajenius, Petra J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2453103/
https://www.ncbi.nlm.nih.gov/pubmed/18565217
http://dx.doi.org/10.1186/1472-6874-8-10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2453103/
https://www.ncbi.nlm.nih.gov/pubmed/18565217
http://dx.doi.org/10.1186/1472-6874-8-10

Ejemplares similares